These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37671311)

  • 1. Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer.
    Koukourakis MI; Xanthopoulou E; Koukourakis IM; Fortis SP; Kesesidis N; Karakasiliotis I; Baxevanis CN
    Cancer Diagn Progn; 2023; 3(5):551-557. PubMed ID: 37671311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer.
    Schou JV; Larsen FO; Sørensen BS; Abrantes R; Boysen AK; Johansen JS; Jensen BV; Nielsen DL; Spindler KL
    Ann Oncol; 2018 Mar; 29(3):610-615. PubMed ID: 29253083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
    Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
    Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy.
    Truelsen CG; Kronborg CS; Sørensen BS; Callesen LB; Spindler KG
    Clin Transl Radiat Oncol; 2022 Sep; 36():9-15. PubMed ID: 35733829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma.
    Verma T; Kumari S; Mishra S; Rastogi M; Tiwari V; Agarwal GR; Anand N; Husain N
    Indian J Pathol Microbiol; 2020; 63(4):521-526. PubMed ID: 33154299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
    Oh CR; Kong SY; Im HS; Kim HJ; Kim MK; Yoon KA; Cho EH; Jang JH; Lee J; Kang J; Park SR; Ryoo BY
    BMC Cancer; 2019 Apr; 19(1):292. PubMed ID: 30935424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Liquid Biopsy to Predict Relapse After Radiotherapy in Squamous Cell Head-Neck and Esophageal Cancer.
    Koukourakis IM; Xanthopoulou E; Koukourakis MI
    Cancer Diagn Progn; 2023; 3(4):403-410. PubMed ID: 37405217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
    Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
    Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers.
    Li BT; Drilon A; Johnson ML; Hsu M; Sima CS; McGinn C; Sugita H; Kris MG; Azzoli CG
    Ann Oncol; 2016 Jan; 27(1):154-9. PubMed ID: 26487589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.
    Koukourakis MI; Xanthopoulou E; Koukourakis IM; Fortis SP; Kesesidis N; Kakouratos C; Karakasiliotis I; Baxevanis CN
    Curr Oncol; 2023 Sep; 30(10):8902-8915. PubMed ID: 37887543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
    Mazurek AM; Rutkowski T; Fiszer-Kierzkowska A; Małusecka E; Składowski K
    Oral Oncol; 2016 Mar; 54():36-41. PubMed ID: 26786940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes.
    Traver S; Scalici E; Mullet T; Molinari N; Vincens C; Anahory T; Hamamah S
    PLoS One; 2015; 10(8):e0136172. PubMed ID: 26288130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
    Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
    Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate Cancer.
    Fettke H; Kwan EM; Bukczynska P; Ng N; Nguyen-Dumont T; Southey MC; Davis ID; Mant A; Parente P; Pezaro C; Hauser C; Azad AA
    Eur Urol Focus; 2021 Nov; 7(6):1287-1291. PubMed ID: 32739405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of plasma cell-free DNA combined with VEGF-C in laryngeal squamous cell carcinoma.
    Huang Q; Ji M; Li F; Li Y; Zhou X; Hsueh CY; Zhou L
    Mol Cell Probes; 2023 Feb; 67():101895. PubMed ID: 36682577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection.
    Kim K; Shin DG; Park MK; Baik SH; Kim TH; Kim S; Lee S
    Ann Surg Treat Res; 2014 Mar; 86(3):136-42. PubMed ID: 24761422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer.
    Corradetti MN; Torok JA; Hatch AJ; Xanthopoulos EP; Lafata K; Jacobs C; Rushing C; Calaway J; Jones G; Kelsey CR; Nixon AB
    Adv Radiat Oncol; 2019; 4(4):748-752. PubMed ID: 31673668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Cell-Free DNA as a Biomarker for Prognosis and Response to Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma.
    Watanabe T; Suzuki Y; Kuroda H; Hiraki H; Suzuki A; Tamura A; Ieko Y; Nishizuka SS; Matsumoto T
    Oncology; 2023; 101(11):714-722. PubMed ID: 37369179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients.
    Zhou X; Li C; Zhang Z; Li DY; Du J; Ding P; Meng H; Xu H; Li R; Ho E; Zhang A; Okunieff P; Lu J; Sha MY
    Sci Rep; 2021 Apr; 11(1):7633. PubMed ID: 33828112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.